甲壳质可吸收缝合线创业计划书(共45页).pdf

《医用甲壳质可吸收(xīshōu)缝合线》创业计划书

目录

1．执行(zhíxíng)总

结································

2

············

2．项目(xiàngmù)背

景································

3

············

3．市场(shìchǎng)机

会································

7

············

4．公司(ɡōnɡsī)战

略································

12

············

5．市场营

销································

14

············

6．生产管

理································

21

············

7．投资分

析································

22

············

8．财务分

析································

26

············

9．管理体

系································

32

············

10．机遇与风

险································

34

········

11．风险资本的退

出································

35

···

附录

1．市场容量估

算································

36

·······

2．市场(shìchǎng)调查和定性分

析38

·······························

3．财务(cáiwù)附

表································

44

············

1/53

1.执行(zhíxíng)总结

1.1.公司(ɡōnɡsī)

甲壳质材料(cáiliào)研究开发(kāifā)有限责任公司是一个提议中的公

司，它拥有甲壳质纤维制备的专利技术，提倡科技为本的绿色生活新理念，为

人类提供尽善尽美(jìnshànjìnměi)的天然生物产品。

我国医用缝合线每年(měinián)约有15亿人民币的市场需求，其中可吸收

缝合线约有7.5亿。公司成立初期生产医用甲壳质可吸收缝合线，以满足迅速

发展的可吸收缝合线市场的需求，使用投资建厂解决方案，针对解决PGA

（PolyglycolicAcid聚乙二醇酸）类可吸收缝合线大部分依赖进口、价格昂

贵、影响提高人们医疗水平的问题。

公司注重短期目标与长远战略的结合，中长期目标将逐步拓宽产品领域，

涉足甲壳质医用抗菌材料、药物缓释材料、人造器官、化妆品、